Our results demonstrated that administration of I-BET151 effectively improved renal function and ameliorated renal fibrosis in association with inhibition of TGFβ/Smad3, ERK1/2 and NF-kB signaling and suppression of inflammation. Here, SMAD3 is linked to renal fibrosis.